4//SEC Filing
CAIN CHRISTOPHER W. 4
Accession 0000899243-22-021643
CIK 0001622229other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:09 PM ET
Size
10.0 KB
Accession
0000899243-22-021643
Insider Transaction Report
Form 4
CAIN CHRISTOPHER W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+30,700→ 30,700 totalExercise: $4.59Exp: 2032-06-07→ Common Stock (30,700 underlying)
Footnotes (1)
- [F1]This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001817733
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:09 PM ET
- Size
- 10.0 KB